Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
ClinicalTrials.gov study NCT00004040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00008268. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05847569. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Access the Safety and Efficacy of CT0590 in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05066022. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transp
ClinicalTrials.gov study NCT05280275. IPD Sharing: NO. Countries: 1. Publications: 0.
SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
ClinicalTrials.gov study NCT04684108. IPD Sharing: NO. Countries: 1. Publications: 0.
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06581640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea
ClinicalTrials.gov study NCT03288974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Descartes-25 in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05113342. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05372354. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs
ClinicalTrials.gov study NCT04106700. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma
ClinicalTrials.gov study NCT01742793. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00938626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07266441. IPD Sharing: YES. Countries: 0. Publications: 0.
Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01985477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma
ClinicalTrials.gov study NCT01954784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients
ClinicalTrials.gov study NCT04303091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Pati
ClinicalTrials.gov study NCT05284591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT
ClinicalTrials.gov study NCT05497102. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
ClinicalTrials.gov study NCT05822037. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.